BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 29742076)

  • 1. Update on hairy cell leukemia.
    Kreitman RJ; Arons E
    Clin Adv Hematol Oncol; 2018 Mar; 16(3):205-215. PubMed ID: 29742076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy cell leukemia: present and future directions.
    Kreitman RJ
    Leuk Lymphoma; 2019 Dec; 60(12):2869-2879. PubMed ID: 31068044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I manage patients with hairy cell leukaemia.
    Thompson PA; Ravandi F
    Br J Haematol; 2017 May; 177(4):543-556. PubMed ID: 28146266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hairy cell leukemia.
    Chihara D; Kreitman RJ
    Expert Rev Hematol; 2020 Oct; 13(10):1107-1117. PubMed ID: 32893700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the biology and treatment options for hairy cell leukemia.
    Jain P; Pemmaraju N; Ravandi F
    Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
    Kreitman RJ; Arons E
    Blood Rev; 2022 Jan; 51():100888. PubMed ID: 34535326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hairy Cell Leukaemia.
    Cross M; Dearden C
    Curr Oncol Rep; 2020 Apr; 22(5):42. PubMed ID: 32297104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoconjugates and new molecular targets in hairy cell leukemia.
    Kreitman RJ
    Hematology Am Soc Hematol Educ Program; 2012; 2012():660-6. PubMed ID: 23233649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
    Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
    Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant.
    King AC; Kabel CC; Pappacena JJ; Stump SE; Daley RJ
    Ann Pharmacother; 2019 Sep; 53(9):922-932. PubMed ID: 30841702
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
    Arons E; Zhou H; Sokolsky M; Gorelik D; Potocka K; Davies S; Fykes E; Still K; Edelman DC; Wang Y; Meltzer PS; Raffeld M; Wiestner A; Xi L; Wang HW; Stetler-Stevenson M; Yuan C; Kreitman RJ
    PLoS One; 2020; 15(2):e0227586. PubMed ID: 32040482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairy cell leukemia: a brief update on current knowledge and treatment prospects.
    Puła A; Robak T
    Curr Opin Oncol; 2021 Sep; 33(5):412-419. PubMed ID: 34264896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment options in hairy cell leukemia with focus on BRAF inhibitors.
    Falini B; Tiacci E
    Hematol Oncol; 2019 Jun; 37 Suppl 1():30-37. PubMed ID: 31187521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
    Troussard X; Maître E; Cornet E
    Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.
    Paillassa J; Safa F; Troussard X
    Ther Adv Hematol; 2022; 13():20406207221090886. PubMed ID: 35450208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology and Treatment of Hairy Cell Leukemia.
    Paillassa J; Troussard X
    Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoconjugates in the management of hairy cell leukemia.
    Kreitman RJ; Pastan I
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):236-45. PubMed ID: 26614902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
    Troussard X; Maître E; Paillassa J
    Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.